Form D · Biotechnology
Twist Bioscience Corp
San Francisco, CA · CIK 0001581280
Offering snapshot reported Apr 2, 2018 · SEC filing
- Reported sold
- $50M Offering amount: $85M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 19, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 2, 2018 | Initial | $50,000,000 | No comparison | 1 | SEC filing |
| Dec 29, 2017 | Amendment | $74,949,996 | $14,601,292vs Jun 14, 2017 | 63 | SEC filing |
| Jun 14, 2017 | Amendment | $60,348,704 | $28,152,563vs Mar 27, 2017 | 47 | SEC filing |
| May 18, 2017 | Amendment | $49,310,751 | $17,114,610vs Mar 27, 2017 | 44 | SEC filing |
| Mar 27, 2017 | Initial | $32,196,141 | No comparison | 28 | SEC filing |
| Apr 19, 2016 | Initial | $2,650,000 | No comparison | 46 | SEC filing |
| Jan 20, 2016 | Initial | $61,047,413 | No comparison | 35 | SEC filing |
| Jun 11, 2015 | Initial | $36,999,999 | No comparison | 28 | SEC filing |
| May 28, 2014 | Initial | $25,999,999 | No comparison | 24 | SEC filing |
| Feb 10, 2014 | Amendment | $9,110,714 | $4,361,903vs Jul 12, 2013 | 16 | SEC filing |
| Jul 12, 2013 | Initial | $4,748,811 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-309072
Source: Form D, filed Apr 2, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Banyai | Director, Executive |
| Rob Chess | Director |
| Paul Conley | Director |
| Keith Crandell | Director |
| Fred Craves | Director |
| Solange Glaize | Executive |
| Emily Marine Leproust | Director, Executive |
| Minqi Li | Director |
| Nick Naclerio | Director |
| Bill Peck | Executive |
| Bob Ragusa | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
455 Mission Bay Boulevard South Suite 545
San Francisco, CA, 94158
San Francisco, CA, 94158